Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Status:
Completed
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
This study seeks to investigate the safety, tolerability and efficacy of CT38, an
experimental peptide administered by subcutaneous infusion, in the treatment of ME/CFS
patients.